Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Evidence-Based Practice: Temozolomide Beyond Glioblastoma.

Chua J, Nafziger E, Leung D.

Curr Oncol Rep. 2019 Mar 5;21(4):30. doi: 10.1007/s11912-019-0783-5. Review.

PMID:
30835007
2.

A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas.

Hummel TR, Salloum R, Drissi R, Kumar S, Sobo M, Goldman S, Pai A, Leach J, Lane A, Pruitt D, Sutton M, Chow LM, Grimme L, Doughman R, Backus L, Miles L, Stevenson C, Fouladi M, DeWire M.

J Neurooncol. 2016 Mar;127(1):53-61. doi: 10.1007/s11060-015-2008-6. Epub 2015 Dec 1.

PMID:
26626490
3.

Characterization of gliomas: from morphology to molecules.

Ferris SP, Hofmann JW, Solomon DA, Perry A.

Virchows Arch. 2017 Aug;471(2):257-269. doi: 10.1007/s00428-017-2181-4. Epub 2017 Jul 4. Review.

PMID:
28674742
4.

Anaplastic glioma.

Paleologos NA, Merrell RT.

Curr Treat Options Neurol. 2012 Aug;14(4):381-90. doi: 10.1007/s11940-012-0177-6.

PMID:
22665140
5.

Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.

Turner CD, Gururangan S, Eastwood J, Bottom K, Watral M, Beason R, McLendon RE, Friedman AH, Tourt-Uhlig S, Miller LL, Friedman HS.

Neuro Oncol. 2002 Apr;4(2):102-8. doi: 10.1093/neuonc/4.2.109.

6.

Radiotherapy and temozolomide for newly diagnosed glioblastoma and anaplastic astrocytoma: validation of Radiation Therapy Oncology Group-Recursive Partitioning Analysis in the IMRT and temozolomide era.

Paravati AJ, Heron DE, Landsittel D, Flickinger JC, Mintz A, Chen YF, Huq MS.

J Neurooncol. 2011 Aug;104(1):339-49. doi: 10.1007/s11060-010-0499-8. Epub 2010 Dec 22.

7.

Biomarker-driven diagnosis of diffuse gliomas.

Appin CL, Brat DJ.

Mol Aspects Med. 2015 Nov;45:87-96. doi: 10.1016/j.mam.2015.05.002. Epub 2015 May 21. Review.

PMID:
26004297
8.

Surgery, radiotherapy and temozolomide in treating high-grade gliomas.

Parlato C, Barbarisi M, Moraci M, Moraci A.

Front Biosci. 2006 May 1;11:1280-3.

PMID:
16368514
9.

Anaplastic gliomas in adults: an update.

Izquierdo C, Joubert B, Ducray F.

Curr Opin Oncol. 2017 Nov;29(6):434-442. doi: 10.1097/CCO.0000000000000409. Review.

PMID:
28901965
10.

Evidence-based adjuvant therapy for gliomas: current concepts and newer developments.

Khan MK, Hunter GK, Vogelbaum M, Suh JH, Chao ST.

Indian J Cancer. 2009 Apr-Jun;46(2):96-107. Review.

11.

Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.

Sewing ACP, Lagerweij T, van Vuurden DG, Meel MH, Veringa SJE, Carcaboso AM, Gaillard PJ, Peter Vandertop W, Wesseling P, Noske D, Kaspers GJL, Hulleman E.

J Neurosurg Pediatr. 2017 May;19(5):518-530. doi: 10.3171/2016.9.PEDS16152. Epub 2017 Feb 17.

PMID:
28291423
12.

Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.

Koukourakis GV, Kouloulias V, Zacharias G, Papadimitriou C, Pantelakos P, Maravelis G, Fotineas A, Beli I, Chaldeopoulos D, Kouvaris J.

Molecules. 2009 Apr 16;14(4):1561-77. doi: 10.3390/molecules14041561. Review.

13.

Pediatric glial tumors.

Cohen KJ, Broniscer A, Glod J.

Curr Treat Options Oncol. 2001 Dec;2(6):529-36. Review.

PMID:
12057098
14.

Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.

Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9.

PMID:
16168843
15.

High-grade Gliomas.

Nayak L, Reardon DA.

Continuum (Minneap Minn). 2017 Dec;23(6, Neuro-oncology):1548-1563. doi: 10.1212/CON.0000000000000554. Review.

PMID:
29200110
16.

Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.

Sipos L, Vitanovics D, Afra D.

Ideggyogy Sz. 2004 Nov 20;57(11-12):394-9.

PMID:
15662767
17.

The Role of Molecular Diagnostics in the Management of Patients with Gliomas.

Wirsching HG, Weller M.

Curr Treat Options Oncol. 2016 Oct;17(10):51. doi: 10.1007/s11864-016-0430-4. Review.

PMID:
27501915
18.

Recurrent high-grade glioma.

Quant EC, Drappatz J, Wen PY, Norden AD.

Curr Treat Options Neurol. 2010 Jul;12(4):321-33. doi: 10.1007/s11940-010-0078-5.

PMID:
20842591
19.

Antiangiogenic therapy for high-grade glioma.

Khasraw M, Ameratunga MS, Grant R, Wheeler H, Pavlakis N.

Cochrane Database Syst Rev. 2014 Sep 22;(9):CD008218. doi: 10.1002/14651858.CD008218.pub3. Review. Update in: Cochrane Database Syst Rev. 2018 Nov 22;11:CD008218.

PMID:
25242542
20.

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.

Taghian A, Ramsay J, Allalunis-Turner J, Budach W, Gioioso D, Pardo F, Okunieff P, Bleehen N, Urtasun R, Suit H.

Int J Radiat Oncol Biol Phys. 1993 Jan 15;25(2):243-9.

PMID:
8380568

Supplemental Content

Support Center